Barclays’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.14M | Buy |
229,873
+103,294
| +82% | +$960K | ﹤0.01% | 2180 |
|
|
2025
Q1 | $851K | Buy |
126,579
+22,265
| +21% | +$150K | ﹤0.01% | 2536 |
|
|
2024
Q4 | $1.11M | Sell |
104,314
-1,572
| -1% | -$16.7K | ﹤0.01% | 2580 |
|
|
2024
Q3 | $1.55M | Buy |
105,886
+59,016
| +126% | +$862K | ﹤0.01% | 2361 |
|
|
2024
Q2 | $566K | Buy |
46,870
+17,876
| +62% | +$216K | ﹤0.01% | 2464 |
|
|
2024
Q1 | $715K | Sell |
28,994
-53,461
| -65% | -$1.32M | ﹤0.01% | 2621 |
|
|
2023
Q4 | $882K | Buy |
+82,455
| New | +$882K | ﹤0.01% | 2687 |
|